Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its ...
News
- Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
- Collaboration with Texas Biomed, SwRI and UT Health San Antonio targets bladder cancer
San Antonio, Texas (October 30, 2019) - The San Antonio Medical Foundation (SAMF) has awarded Texas Biomedical Research Institute Professor ...
- Seattle Genetics: 3Q Earnings Snapshot
The biotechnology company posted revenue of $213.3 million in the period, which beat Street forecasts. Eight analysts surveyed by Zacks expected ...
- Amgen: 3Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $5.74 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks ...
- New Research Study Points to Potential of Oleandrin as Therapeutic Strategy for Treatment of ...
Phoenix Biotechnology, Inc., a San Antonio, Texas-based biotechnology company, was incorporated in Texas in 2003 to develop promising agents ...